Detalhe da pesquisa
1.
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial.
Lancet Oncol
; 24(12): 1359-1374, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37926100
2.
Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis.
Breast Cancer Res Treat
; 197(2): 405-416, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36396774
3.
Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study.
Breast Cancer Res Treat
; 199(1): 35-46, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36859649
4.
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer.
Lancet Oncol
; 23(1): e21-e31, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34973228
5.
Breast cancer radiation therapy - Authors' reply.
Lancet
; 396(10262): 1559-1560, 2020 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33189173
6.
Comparison of CT-volumed supraclavicular fossa radiotherapy planning and conventional simulator-planned defined by bony landmarks for early breast cancer.
Rep Pract Oncol Radiother
; 21(3): 219-24, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27601954
7.
Hypofractionation: The standard for external beam breast irradiation.
Breast
; 69: 410-416, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37120889
8.
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Health Technol Assess
; 27(25): 1-176, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991196
9.
The challenge of equipoise: qualitative interviews exploring the views of health professionals and women with multiple ipsilateral breast cancer on recruitment to a surgical randomised controlled feasibility trial.
Pilot Feasibility Stud
; 8(1): 46, 2022 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35227311
10.
Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results.
Clin Cancer Res
; 28(7): 1323-1334, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35165099
11.
Breast Cancer Management Guidelines During COVID-19 Pandemic.
Indian J Surg
; 82(3): 251-258, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32837081
12.
Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer.
J Clin Oncol
; 38(28): 3261-3272, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32663119
13.
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial.
J Clin Oncol
; 38(5): 423-433, 2020 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31841354
14.
Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial.
Clin Cancer Res
; 25(14): 4248-4254, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31036542
15.
Epileptic seizure abolition with aromatase inhibition.
J Neurol Neurosurg Psychiatry
; 83(12): 1249-50, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23024351